S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
MarketBeat Week in Review – 11/27 - 12/1
New CBOE “special perk” helps traders target income every weekend (Ad)
Mega merger in the works? Humana, Cigna explore big deal
Teen girls are being victimized by deepfake nudes. One family is pushing for more protections
New CBOE “special perk” helps traders target income every weekend (Ad)
US targets oil and natural gas industry's role in global warming with new rule on methane emissions
US joins in other nations in swearing off coal power to clean the climate
New CBOE “special perk” helps traders target income every weekend (Ad)
At COP28 meeting, oil companies pledge to combat methane. Environmentalists call it a "smokescreen"
Pentagon forges new high-tech agreement with Australia, United Kingdom, aimed at countering China
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
MarketBeat Week in Review – 11/27 - 12/1
New CBOE “special perk” helps traders target income every weekend (Ad)
Mega merger in the works? Humana, Cigna explore big deal
Teen girls are being victimized by deepfake nudes. One family is pushing for more protections
New CBOE “special perk” helps traders target income every weekend (Ad)
US targets oil and natural gas industry's role in global warming with new rule on methane emissions
US joins in other nations in swearing off coal power to clean the climate
New CBOE “special perk” helps traders target income every weekend (Ad)
At COP28 meeting, oil companies pledge to combat methane. Environmentalists call it a "smokescreen"
Pentagon forges new high-tech agreement with Australia, United Kingdom, aimed at countering China
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
MarketBeat Week in Review – 11/27 - 12/1
New CBOE “special perk” helps traders target income every weekend (Ad)
Mega merger in the works? Humana, Cigna explore big deal
Teen girls are being victimized by deepfake nudes. One family is pushing for more protections
New CBOE “special perk” helps traders target income every weekend (Ad)
US targets oil and natural gas industry's role in global warming with new rule on methane emissions
US joins in other nations in swearing off coal power to clean the climate
New CBOE “special perk” helps traders target income every weekend (Ad)
At COP28 meeting, oil companies pledge to combat methane. Environmentalists call it a "smokescreen"
Pentagon forges new high-tech agreement with Australia, United Kingdom, aimed at countering China
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
MarketBeat Week in Review – 11/27 - 12/1
New CBOE “special perk” helps traders target income every weekend (Ad)
Mega merger in the works? Humana, Cigna explore big deal
Teen girls are being victimized by deepfake nudes. One family is pushing for more protections
New CBOE “special perk” helps traders target income every weekend (Ad)
US targets oil and natural gas industry's role in global warming with new rule on methane emissions
US joins in other nations in swearing off coal power to clean the climate
New CBOE “special perk” helps traders target income every weekend (Ad)
At COP28 meeting, oil companies pledge to combat methane. Environmentalists call it a "smokescreen"
Pentagon forges new high-tech agreement with Australia, United Kingdom, aimed at countering China

ARCA biopharma Stock Price, News & Analysis (NASDAQ:ABIO)

$1.83
+0.01 (+0.55%)
(As of 12/1/2023 ET)
Compare
Today's Range
$1.81
▼
$1.88
50-Day Range
$1.75
▼
$2.05
52-Week Range
$1.74
▼
$2.70
Volume
19,096 shs
Average Volume
16,755 shs
Market Capitalization
$26.37 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media

ABIO stock logo

About ARCA biopharma Stock (NASDAQ:ABIO)

ARCA biopharma, Inc., a clinical development stage biopharmaceutical company, engages in the development and commercialization of genetically targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase IIb trial for the treatment of atrial fibrillation in patients with chronic heart failure. It is also developing Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), a protein therapeutic that is in Phase IIb clinical trial for the treatment for COVID-19. ARCA biopharma, Inc. has a collaboration agreement with LabCorp to develop genetic test for GENETIC-AF clinical trial. The company was founded in 2004 and is headquartered in Westminster, Colorado.

ABIO Stock Price History

ABIO Stock News Headlines

November 28, 2023 | americanbankingnews.com
ARCA biopharma (NASDAQ:ABIO) Stock Price Passes Above 50 Day Moving Average of $1.94
November 28, 2023 | americanbankingnews.com
ARCA biopharma (NASDAQ:ABIO) Receives New Coverage from Analysts at StockNews.com
December 2, 2023 | DTI Trader (Ad)
All the trading advice you’ve ever received boils down to this
All the trading advice you’ve ever received boils down to one goal and one goal only: finding a reliable edge in the markets. If you can do that, grab hold of it and never let go. Because once you have that edge, and you can count on it, you never need to do anything else.
November 4, 2023 | msn.com
Sean Hingorani Rides Third-Place Phoenix Finish to Historic ARCA Menards Series West Title
November 3, 2023 | msn.com
Phoenix Results: November 3, 2023 (ARCA Menards Series)
October 25, 2023 | msn.com
ARCA champion Jesse Love to drive for RCR in Xfinity Series in 2024
October 22, 2023 | finanznachrichten.de
ARCA biopharma, Inc.: ARCA biopharma Announces Third Quarter 2023 Financial Results
October 18, 2023 | msn.com
ARCA biopharma GAAP EPS of -$0.10
December 2, 2023 | DTI Trader (Ad)
All the trading advice you’ve ever received boils down to this
All the trading advice you’ve ever received boils down to one goal and one goal only: finding a reliable edge in the markets. If you can do that, grab hold of it and never let go. Because once you have that edge, and you can count on it, you never need to do anything else.
October 18, 2023 | finance.yahoo.com
ARCA biopharma Announces Third Quarter 2023 Financial Results
September 27, 2023 | msn.com
ARCA legend Kimmel keeps the racing itch scratched as a truck chief with TRICON
September 21, 2023 | msn.com
ARCA Wunderkind: NASCAR Fans Should 'Love' Who's Coming Down the Road
September 10, 2023 | uk.finance.yahoo.com
ABIO - ARCA biopharma, Inc.
September 8, 2023 | msn.com
Rookie Connor Mosack wins first career ARCA race at Kansas Speedway
September 6, 2023 | msn.com
Five drivers to watch in Friday’s ARCA Sioux Chief Fast Track 150 at Kansas Speedway
August 22, 2023 | msn.com
Racing for Stride ARCA driver honors disabled veterans
August 18, 2023 | msn.com
Watkins Glen Day 1 Recap: ARCA race comes down to final turn; tough day for Frankie Muniz
August 18, 2023 | msn.com
Love bumps Zilisch on last lap to win ARCA race at Watkins Glen
August 18, 2023 | msn.com
Frankie Muniz sees Watkins Glen as chance to earn first career ARCA victory
August 14, 2023 | msn.com
Corey LaJoie enters ARCA Menards Series race for Watkins Glen weekend
August 13, 2023 | msn.com
ARCA drivers Christian Rose, Conner Jones get into heated scuffle after spin out
August 11, 2023 | yahoo.com
Actor Turned Racer Frankie Muniz Is No Joke in ARCA Racing Series
July 30, 2023 | finanznachrichten.de
ARCA biopharma, Inc.: ARCA biopharma Announces Second Quarter 2023 Financial Results
July 27, 2023 | sports.yahoo.com
Sekisui Voltek Announces Sponsorship of Coldwater's Rodgers for ARCA race
July 21, 2023 | sports.yahoo.com
POCONOTES: Actor Muniz in middle of ARCA points battle
July 21, 2023 | finance.yahoo.com
ARCA biopharma Announces Second Quarter 2023 Financial Results
July 15, 2023 | msn.com
Fenhaus wins Calypso 150 in ARCA Menards Series
See More Headlines
Receive ABIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ARCA biopharma and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
10/18/2023
Today
12/02/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/23/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Diagnostic substances
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ABIO
CUSIP
N/A
CIK
907654
Web
arcabio.com
Phone
(720) 940-2100
Fax
720-208-9261
Employees
5
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($0.37)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-9,930,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-13.61%
Return on Assets
-13.12%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
39.21
Quick Ratio
39.21

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.89 per share
Price / Book
0.63

Miscellaneous

Outstanding Shares
14,410,000
Free Float
N/A
Market Cap
$26.37 million
Optionable
Not Optionable
Beta
1.43
Beginner's Guide to Pot Stock Investing Cover
Beginner's Guide to Pot Stock Investing

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Dr. Michael R. Bristow M.D. (Age 78)
    Ph.D., Co-Founder, President, CEO & Director
    Comp: $358.8k
  • Mr. Thomas A. Keuer (Age 64)
    Chief Operating Officer
    Comp: $360.59k
  • Mr. C. Jeffrey Dekker CPA (Age 58)
    Chief Financial Officer

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions














ABIO Stock Analysis - Frequently Asked Questions

How have ABIO shares performed in 2023?

ARCA biopharma's stock was trading at $2.37 at the beginning of 2023. Since then, ABIO shares have decreased by 22.8% and is now trading at $1.83.
View the best growth stocks for 2023 here.

When is ARCA biopharma's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, February 23rd 2024.
View our ABIO earnings forecast.

How were ARCA biopharma's earnings last quarter?

ARCA biopharma, Inc. (NASDAQ:ABIO) released its earnings results on Wednesday, October, 18th. The biopharmaceutical company reported ($0.10) earnings per share (EPS) for the quarter.

What is Michael R. Bristow's approval rating as ARCA biopharma's CEO?

1 employees have rated ARCA biopharma Chief Executive Officer Michael R. Bristow on Glassdoor.com. Michael R. Bristow has an approval rating of 100% among the company's employees. This puts Michael R. Bristow in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of ARCA biopharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ARCA biopharma investors own include Aurora Cannabis (ACBFF), MannKind (MNKD), Bausch Health Companies (BHC), Biocept (BIOC), Novavax (NVAX), AVEO Pharmaceuticals (AVEO), Gilead Sciences (GILD), iBio (IBIO), Nabriva Therapeutics (NBRV) and Synergy Pharmaceuticals (SGYP).

Who are ARCA biopharma's major shareholders?

ARCA biopharma's stock is owned by many different institutional and retail investors. Top institutional shareholders include Newtyn Management LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Christopher David Ozeroff, Fund Lp Funicular and Robert E Conway.
View institutional ownership trends.

How do I buy shares of ARCA biopharma?

Shares of ABIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:ABIO) was last updated on 12/2/2023 by MarketBeat.com Staff

My Account -